Genophe Biotech Private Limited - Due diligence report

A 360° intelligence report on Genophe Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2018-01-05 Bangalore North, Karnataka Active Unlisted
Share
Connect MCP
GB Genophe Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genophe Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
64/100
Trust Score
Moderate

Genophe Biotech Private Limited is assessed as Moderate with a Trust Score of 64/100. Genophe Biotech Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Life Sciences sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 14 Aug 2026 from the latest processed filings. Genophe Biotech Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 auditor resignation(s) filed - latest: Sai Ganesh Karthik and Associates on 2020-08-12.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
GEETIKA SINGH 01234567 Director 01/04/2018 6 yrs Approved
KASI RAJGOPAL 01234567 Director 01/04/2018 6 yrs Approved
KALASTAUADI CHANDRASHEKAR TEJUS BABA 01234567 Director 01/04/2018 6 yrs Approved
THIRUNEELAKANTAN SRINATH 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 55
Growth signals & trust indicators
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
1 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view36/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Dec 2020
Director ceased
GEETIKA SINGH
05 Aug 2020
Director appointed
GEETIKA SINGH (Director)
13 Mar 2020
Director ceased
ARUN SHASTRY
Director ceased
RAV DEEP SINGH ANAND
31 Dec 2019
Director ceased
KASI RAJGOPAL
Director ceased
KALASTAUADI CHANDRASHEKAR TEJUS BABA
12 Dec 2018
Director appointed
KASI RAJGOPAL (Director)
05 Oct 2018
Director appointed
KALASTAUADI CHANDRASHEKAR TEJUS BABA (Director)
05 Jan 2018
Incorporated
Registered with Roc Bangalore
Director appointed
THIRUNEELAKANTAN SRINATH (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Geo Marine Solutions Private Limited U74900KA2011PTC201712 Mangalore, Karnataka, India
Pharmaquant Insights Private Limited U74999WB2019PTC230939 Kolkata, West Bengal, India
Pharmacoevidence Private Limited U72100PB2020PTC051449 Mohali, Punjab, India
Varaha U72900HR2022PTC124578 Dlf Ph-Ii, Haryana, India
Premas Biotech U24232HR2005PTC035932 Manesar, Haryana, India
Mms Holdings U85195KA2007PTC043866 Bangalore, Karnataka, India
Parpharm U24232TN2013PTC093471 Chennai, Tamil Nadu, India
Epsilonpharma U24230GJ1998PTC084755 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genophe Biotech Private Limited before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genophe Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Genophe Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Genophe Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Genophe Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genophe Biotech Private Limited an active company?

Genophe Biotech Private Limited has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Genophe Biotech Private Limited financially healthy?

Genophe Biotech Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Genophe Biotech Private Limited?

Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genophe Biotech Private Limited?

See the directors and ownership sections above for board and shareholding detail. 4 active director(s) are on record.

Does Genophe Biotech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Genophe Biotech Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Genophe Biotech Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.